- Form submit
- Fetch company site
- Claude scores fit
Auto-qualify inbound leads before a rep sees them
Score every demo request against your ICP, update HubSpot and ping the right rep in Slack within a minute of the form submit.
OpenChart lets Claude or Codex annotate chart setups, write indicators, and investigate price alerts, saving research to a local workspace.
OpenChart lets Claude or Codex annotate chart setups, write indicators, and investigate price alerts, saving research to a local workspace.
OpenChart is a desktop charting app that connects to your own Claude, Codex or Gemini account. You tell the agent what to watch, and it writes Tea monitors (the project's market-analysis language) that evaluate incoming data. When an alert fires, the agent researches the move. You can also select a chart range or draw a line or zone, and the agent pins source-linked annotations to the bars.
The README is a product description and reports no results or measurements. It says there are no software limits on charts, indicators or alerts. I did not find anything on the quality of the agent's research.
Desktop is free, but AI usage is billed under your agent provider's plan, and optional Cloud market data costs extra. The prebuilt download is macOS Apple Silicon only.
I keep my charts and notes in a local folder at [folder path]. When a price alert fires on [ticker or asset], investigate what moved it by checking recent news, volume, and levels on [timeframe] charts, then save a short research note in that folder with your findings and the chart levels you marked. You're done when the note covers the likely cause, key support and resistance, and what to watch next. This is research only, so do not place any trades.
Score every demo request against your ICP, update HubSpot and ping the right rep in Slack within a minute of the form submit.
Every new Zendesk ticket gets a category, priority and sentiment tag plus a draft reply in an internal note before an agent opens it.
Copilot and Claude review each PR for bugs, missing tests and risky changes before a human looks, so reviewers can focus on design.